NeuroBo Pharmaceuticals, Inc. announced on January 14, 2022, Mr. Douglas J. Swirsky provided notice of his resignation from the Board of Directors, effective immediately. Andrew I. Koven, a current director of the Company was elected Chairman of the Board and Michael Salsbury, a current director of the Company was appointed to the Audit Committee of the Board and appointed Chairman of the Audit Committee. As a result, the Audit Committee of the Board currently consists of Jason Groves, Andrew I. Koven, Michael Salsbury.